Delivery Order SPE2DB22D1017-SPE2DB24FF1UY
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a potential value of $7,217.61 and a period of performance ending on March 7, 2024. This order is not associated with a set-aside program and is part of a larger indefinite delivery contract...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a potential value of $11,536.38 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used for this award. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564257960 - TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,741.68 and a period of performance through April 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distributor. The order is for TRULICITY 3 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The award has a potential value of $3,919.68 and a completion date of January 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,364.38 and a period of performance through March 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceuticals. The $6,570.83 delivery order was issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $6,386.16 and a completion date of February 2, 2024. This order is issued under an indefinite delivery contract (IDC) held by...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The award has a potential value of $3,047.94 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. Amerisourcebergen Drug Corp is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $10,450.08 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $1,157.93 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is not designated as a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF1UYDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The total potential value of this order is $11,611.20 and the period of performance ends on January 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA as the prime contractor, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 1/25/24 |